Imaging in 2020
September 30 – October 4, 2001

 Organizers: Thomas Meade, Daniel Sullivan, and James Tatum


Ultrasonic Microscanning: Present Status and Future Prospects
Peter Wells, University of Bristol, UK

[No Title]
Truman Brown, Columbia University

Chair: Tom Budinger, University of California, Berkeley

Synergy between Imaging and High Throughput Tissue Analysis
King Chuen P. Li, Stanford University

Molecular Imaging with PET: A Technological Perspective
Simon Cherry, University of California, Davis

Optical Coherence Tomography for Structural and Functional Imaging
James Fujimoto, Massachusetts Institute of Technology

Targeting of Paramagnetic Complexes to Proteins and Cells for Novel Diagnostic Applications in MRI
Silvio Aime, University of Torino, Italy

PET and SPECT Strategies for Molecular Imaging
David Piwnica-Worms, Washington University, St. Louis

Imaging Signal Transduction with Genetically Encoded Indicators
Martin Pomper, Harvard University / MGH

Chair: Truman Brown, Columbia University

Structural and Functional Contrast in Diffuse Optical Mammography
Bruce Tromberg, University of California, Irvine

Responsive MR Agents: Is Fast Water Exchange Necessary?
A. Dean Sherry, University of Texas at Dallas

Use of Quantum Dots in Cellular Imaging
Walt Mahoney, Quantum Dot Corporation

Immune Cell Trafficking in Autoimmunity and Neoplastic Disease
Chris Contag, Stanford University

Chair: Juri Gelovani, Memorial Sloan-Kettering Cancer Center

Multimodal Imaging of Vertebrate Neural Development
Russ Jacobs, California Institute of Technology

Early Detection of Chemotherapy Response in Tumors using the MR-visible Apparent Diffusion Coefficient of Water
Robert Gillies, University of Arizona Cancer Center

MR Imaging with Intermolecular Multiple-Quantum Coherences
Warren Warren, Princeton University

Defining Molecular Targets for Treatment and Imaging
Ed Sausville, National Cancer Institute

NCI Discussion Session: NCI Challenge on Imaging Agent Development

NMR and NIR Molecular Imaging of Cancer
Jerry Glickson, University of Pennsylvania

[No title]
Juri Gelovani, Memorial Sloan-Kettering Cancer Center

Chair: Tom Meade,California Institute of Technology

Lanthanide Chelates: Multipurpose Probes for Biomedical Imaging
Darryl Bornhop, Texas Tech University

Onward and Downward: Higher MRI Field Strength means Lower Detection Thresholds for Contrast Reagents
Charles Springer, Brookhaven National Laboratory

Group Discussion

Comments are closed.